Literature DB >> 21643886

Radiological features of Paget disease of bone associated with VCP myopathy.

Farzin Farpour1, Jamshid Tehranzadeh, Sandra Donkervoort, Charles Smith, Barbara Martin, Pari Vanjara, Kathryn Osann, Virginia E Kimonis.   

Abstract

OBJECTIVE: Mutations in the Valosin-containing protein (VCP) gene cause a unique disorder characterized by classic Paget disease of bone (PDB), inclusion body myopathy, and frontotemporal dementia (IBMPFD). Our objective was to analyze the radiographic features of PDB associated with VCP mutations since there is a dearth of literature on the PDB component of VCP disease.
MATERIALS AND METHODS: Radiographic bone surveys were examined in 23 individuals with VCP mutation and compared with their unaffected relatives. Laboratory testing relevant for VCP disease was performed in all individuals.
RESULTS: Of the 17 affected individuals with clinical manifestations of VCP disease, 16 of whom had myopathy, radiographic analysis revealed classic PDB in 11 individuals (65%). The mean age of diagnosis for myopathy was 43.8 years and for PDB was 38.1 years of age. Radiological evidence of PDB was seen in one individual (16%) amongst six clinically asymptomatic VCP mutation carriers. Alkaline phosphatase was a useful marker for diagnosing PDB in VCP disease.
CONCLUSIONS: Radiographic findings of classic PDB are seen in 52% of individuals carrying VCP mutations at a significantly younger age than conventional PDB. Screening for PDB is warranted in at-risk individuals because of the benefit of early treatment with the new powerful bisphosphonates that hold the potential for prevention of disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21643886     DOI: 10.1007/s00256-011-1193-4

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  18 in total

1.  Mutations of SQSTM1 are associated with severity and clinical outcome in paget disease of bone.

Authors:  Micaela Rios Visconti; Anne L Langston; Nerea Alonso; Kirsteen Goodman; Peter L Selby; William D Fraser; Stuart H Ralston
Journal:  J Bone Miner Res       Date:  2010-11       Impact factor: 6.741

Review 2.  Paget's disease of bone: a review.

Authors:  Matteo Colina; Renato La Corte; Francesco De Leonardis; Francesco Trotta
Journal:  Rheumatol Int       Date:  2008-07-01       Impact factor: 2.631

Review 3.  Paget's disease of bone and genetic disorders of RANKL/OPG/RANK/NF-kappaB signaling.

Authors:  Michael P Whyte
Journal:  Ann N Y Acad Sci       Date:  2006-04       Impact factor: 5.691

4.  Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia.

Authors:  M J Kovach; B Waggoner; S M Leal; D Gelber; R Khardori; M A Levenstien; C A Shanks; G Gregg; M T Al-Lozi; T Miller; W Rakowicz; G Lopate; J Florence; G Glosser; Z Simmons; J C Morris; M P Whyte; A Pestronk; V E Kimonis
Journal:  Mol Genet Metab       Date:  2001-12       Impact factor: 4.797

Review 5.  Paget's disease of bone: review with emphasis on radiologic features, Part II.

Authors:  J M Mirra; E W Brien; J Tehranzadeh
Journal:  Skeletal Radiol       Date:  1995-04       Impact factor: 2.199

6.  Evaluation of the role of Valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone.

Authors:  Gavin J A Lucas; Sarju G Mehta; Lynne J Hocking; Tracy L Stewart; Tim Cundy; Geoff C Nicholson; John P Walsh; William D Fraser; Giles D J Watts; Stuart H Ralston; Virginia E Kimonis
Journal:  Bone       Date:  2005-09-30       Impact factor: 4.398

7.  Risedronate, a highly effective oral agent in the treatment of patients with severe Paget's disease.

Authors:  F R Singer; T L Clemens; R A Eusebio; P J Bekker
Journal:  J Clin Endocrinol Metab       Date:  1998-06       Impact factor: 5.958

Review 8.  VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: review of a unique disorder.

Authors:  Virginia E Kimonis; Erin Fulchiero; Jouni Vesa; Giles Watts
Journal:  Biochim Biophys Acta       Date:  2008-09-18

9.  Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts.

Authors:  Jouni Vesa; Hailing Su; Giles D Watts; Sabine Krause; Maggie C Walter; Barbara Martin; Charles Smith; Douglas C Wallace; Virginia E Kimonis
Journal:  Neuromuscul Disord       Date:  2009-10-13       Impact factor: 4.296

10.  Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein.

Authors:  Giles D J Watts; Jill Wymer; Margaret J Kovach; Sarju G Mehta; Steven Mumm; Daniel Darvish; Alan Pestronk; Michael P Whyte; Virginia E Kimonis
Journal:  Nat Genet       Date:  2004-03-21       Impact factor: 38.330

View more
  7 in total

1.  Global gene profiling of VCP-associated inclusion body myopathy.

Authors:  Angèle Nalbandian; Svetlana Ghimbovschi; Shlomit Radom-Aizik; Eric Dec; Jouni Vesa; Barbara Martin; Susan Knoblach; Charles Smith; Eric Hoffman; Virginia E Kimonis
Journal:  Clin Transl Sci       Date:  2012-04-04       Impact factor: 4.689

2.  A progressive translational mouse model of human valosin-containing protein disease: the VCP(R155H/+) mouse.

Authors:  Angèle Nalbandian; Katrina J Llewellyn; Mallikarjun Badadani; Hong Z Yin; Christopher Nguyen; Veeral Katheria; Giles Watts; Jogeshwar Mukherjee; Jouni Vesa; Vincent Caiozzo; Tahseen Mozaffar; John H Weiss; Virginia E Kimonis
Journal:  Muscle Nerve       Date:  2012-11-21       Impact factor: 3.217

Review 3.  The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis.

Authors:  Angèle Nalbandian; Sandra Donkervoort; Eric Dec; Mallikarjun Badadani; Veeral Katheria; Prachi Rana; Christopher Nguyen; Jogeshwar Mukherjee; Vincent Caiozzo; Barbara Martin; Giles D Watts; Jouni Vesa; Charles Smith; Virginia E Kimonis
Journal:  J Mol Neurosci       Date:  2011-09-03       Impact factor: 3.444

4.  A clinicopathologic study of malignancy in VCP-associated multisystem proteinopathy.

Authors:  Alyaa Shmara; Mari Perez-Rosendahl; Kady Murphy; Ashley Kwon; Charles Smith; Virginia Kimonis
Journal:  Orphanet J Rare Dis       Date:  2022-07-15       Impact factor: 4.303

Review 5.  Multisystem Proteinopathy Due to VCP Mutations: A Review of Clinical Heterogeneity and Genetic Diagnosis.

Authors:  Gerald Pfeffer; Grace Lee; Carly S Pontifex; Roberto D Fanganiello; Allison Peck; Conrad C Weihl; Virginia Kimonis
Journal:  Genes (Basel)       Date:  2022-05-27       Impact factor: 4.141

6.  Genotype-phenotype studies of VCP-associated inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia.

Authors:  S G Mehta; M Khare; R Ramani; G D J Watts; M Simon; K E Osann; S Donkervoort; E Dec; A Nalbandian; J Platt; M Pasquali; A Wang; T Mozaffar; C D Smith; V E Kimonis
Journal:  Clin Genet       Date:  2012-10-04       Impact factor: 4.438

7.  VCP/p97 inhibitor CB-5083 modulates muscle pathology in a mouse model of VCP inclusion body myopathy.

Authors:  Cheng Cheng; Lan Weiss; Henri Leinonen; Alyaa Shmara; Hong Z Yin; Timothy Ton; Annie Do; Jonathan Lee; Lac Ta; Eshanee Mohanty; Jesse Vargas; John Weiss; Krzysztof Palczewski; Virginia Kimonis
Journal:  J Transl Med       Date:  2022-01-08       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.